Transcriptomics Analysis Reveals Dual Axes of Metabolic and Immune Dysregulation in the Progression of NAFLD to HCC - Patodia - 2026 - Natural Sciences

Wiley Online Library·May 12

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A study has analyzed the progression of non-alcoholic fatty liver disease (NAFLD) to hepatocellular carcinoma (HCC) using transcriptomics. The research appears to focus on the relationship between metabolic and immune dysregulation, which may be relevant to understanding similar dynamics in other types of cancer. Various studies and reviews are exploring the interplay between metabolic and immune processes in different cancers, including liver, ovarian, breast, and prostate cancer.

Full coverage

Immune regulation and therapeutic targets in sepsis: insights from single-cell transcriptomics

Frontiers·May 4

Decoding the CAF–TAM axis: multi-omics dissection and therapeutic targeting of stromal–immune crosstalk in the tumor microenvironment

Nature·Apr 18

Molecular mechanisms and clinical significance of the glioma metabolic-immune axis: a comprehensive review

Frontiers·May 1

Spatial single-cell landscape of tumor-associated macrophages and their crosstalk with the tumor microenvironment

Nature·May 19

Spatial Transcriptomics and snRNA-seq Expose CAF Niches Orchestrating Dual Stromal-Immune Barriers in Hepatocellular Carcinoma

Wiley & Sons·Oct 7

Spatial profiling of the metabolism-immune axis in ovarian cancer

Frontiers·Jan 29

COL3A1high cancer-associated fibroblasts orchestrate metabolic and immune microenvironments to confer chemoresistance in breast cancer | npj Precision Oncology

Nature·Feb 23

Integrative single-cell and spatial transcriptomics with explainable AI reveal lethal prognostic axis in prostate cancer

Nature·Jan 6

View original report at Wiley Online Library ↗

Fetching the latest headlines…